Ozempic breath,” which got the moniker from the GLP-1 causing bad breath, has made mints and gum a premium product.

Kirk Tanner sees opportunities for the chocolate maker, as it navigates weight-loss drugs and stretched consumers.

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.

The Hershey Co. began fiscal 2026 with nearly 11% growth in first-quarter sales, boosted by last year’s LesserEvil ...

Sales of Hershey's Ice Breakers rose 8% in the first quarter, thanks to the trend.

Hershey's chief executive has credited the spread of Ozempic and other weight-loss drugs for an 8% jump in sales of the ...

Andrew Archambault, US president at The Hershey Co., is leaving the chocolate and snack maker next month after just over a year at the company. Plans call for Archambault to depart on May 1, Hershey ...

Hershey beat first-quarter earnings estimates, helped by strong demand for its healthier snack brands, such as LesserEvil popcorn and its mints, as eating habits shift amid the growing use of GLP‑1 ...

Hershey's gum and mint sales are rising as GLP-1 weight-loss drug users seek relief from side effects like 'Ozempic breath'.

The US snacks giant’s first-quarter sales were also given a boost by its acquisition of organic firm LesserEvil.

While the Reese’s maker has “made tremendous progress,” there is still “a ton of work to do” as consumers pay more attention ...